Home Newsfeeds Knightscope Granted U.S. Patent Titled ‘Autonomous parking monitor’

Knightscope Granted U.S. Patent Titled ‘Autonomous parking monitor’

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11417210.PN.&OS=PN/11417210&RS=PN/11417210

byBenzinga Newsdesk

August 16, 2022

1 minute read

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11417210.PN.&OS=PN/11417210&RS=PN/11417210

No Credit Card? No Car! Avis Budget Fined $275K For Turning Away Customers: Report

By Lekha Gupta

August 16, 9:15 AM

Avis Budget Group Inc (NASDAQ: CAR) was reportedly fined $275,000 by New York state for refusing to rent vehicles to customers who did not have credit cards.

CAR

Nokia Q2 Highlights; 3% Topline Decline, Apple Partnership And Strong Enterprise Performance

By Anusuya Lahiri

July 20, 7:33 AM

Nokia Corp (NYSE: NOK) reported a second-quarter FY23 net sales decline of 3% year-on-year (0% in constant currency) to €5.71 billion ($6.22 billion), missing the consensus of $6.38 billion.

AAPL

Ford Plunges Following Supply Chain Warning: What’s Going On?

By Melanie Schaffer

Yesterday, 10:53 AM

Ford Motor Company (NYSE: F) stock was plunging Tuesday after the legacy-turned-EV manufacturer announced that it’s unable to roll out 40,000 to 45,000 vehicles this quar

Soleno Therapeutics Announces Proposed Public Offering Of Common Stock And/Or Pre-Funded Warrants; No Size Disclosed And A $30M Concurrent Private Placement Of Common Stock And/Or Pre-Funded Warrants

By Benzinga Newsdesk

September 27, 4:10 PM

Soleno Therapeutics, Inc. (NASDAQ:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to

SLNO

Knightscope Granted U.S. Patent Titled ‘Autonomous parking monitor’

Related Posts

No Credit Card? No Car! Avis Budget Fined $275K For Turning Away Customers: Report

Nokia Q2 Highlights; 3% Topline Decline, Apple Partnership And Strong Enterprise Performance

Ford Plunges Following Supply Chain Warning: What’s Going On?

Soleno Therapeutics Announces Proposed Public Offering Of Common Stock And/Or Pre-Funded Warrants; No Size Disclosed And A $30M Concurrent Private Placement Of Common Stock And/Or Pre-Funded Warrants